文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

首次通过实时逆转录聚合酶链反应在胸腔积液中检出SARS-CoV-2

First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid.
PubMed 文献 · Chest · 2020-06-11
一句话结论病例报告首次描述经超声引导胸腔穿刺获取的胸腔积液中检出SARS-CoV-2,提示胸腔积液虽不常见但可能是COVID-19的潜在采样部位。

本文报告一例经超声引导胸腔穿刺获取胸腔积液,并通过实时逆转录聚合酶链反应检出SARS-CoV-2的病例,为首次报道。COVID-19诊断金标准为鼻咽拭子核酸检测,但受限于该技术敏感性,胸部影像学在诊断评估中起关键补充作用,并可发现非典型表现及潜在替代采样靶点(如胸腔积液)。胸腔积液在COVID-19中不常见,但及时识别这一潜在定位可能有助于优化诊断评估及患者管理。

要点

  • 病例报告首次描述经超声引导胸腔穿刺获取的胸腔积液中实时逆转录聚合酶链反应检出SARS-CoV-2。
  • COVID-19诊断金标准为鼻咽拭子实时逆转录聚合酶链反应核酸检测。
  • 由于鼻咽拭子技术敏感性有限,胸部影像学在诊断评估中起关键补充作用,并可发现非典型表现及潜在替代采样靶点(如胸腔积液)。
  • 胸腔积液在COVID-19患者中不常见,但及时识别这一潜在定位可能有助于优化诊断评估及患者管理。

适用人群与场景

  • COVID-19患者,从无症状携带者到ARDS均可出现;胸腔积液仅见于少数患者。

处置流程与药物剂量

  • 通过超声引导胸腔穿刺获取胸腔积液,送实时逆转录聚合酶链反应检测SARS-CoV-2。

研究设计与关键结果

  • 本文为病例报告,首次描述经超声引导胸腔穿刺获取的胸腔积液中实时逆转录聚合酶链反应检出SARS-CoV-2,并详述其主要特征。

证据类型、等级与局限

  • 证据类型:病例报告。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,胸腔积液在COVID-19中不常见,但及时识别这一潜在定位可能有助于优化诊断评估及患者管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Coronavirus disease 2019 (COVID-19) is a pandemic infection due to the spread of a novel coronavirus (severe acute respiratory syndrome coronavirus 2), resulting in a wide range of clinical features, from asymptomatic carriers to ARDS. The gold standard for diagnosis is nucleic acid detection by real-time reverse transcriptase-polymerase chain reaction in nasopharyngeal swabs. However, due to limitations in this technique's sensitivity, thoracic imaging plays a crucial, complementary role in diagnostic evaluation and also allows for detection of atypical findings and potential alternative targets for sampling (eg, pleural effusion). Although less common, pleural involvement has been described in a minority of patients. This report describes the first case of reverse transcriptase-polymerase chain reaction detection of severe acute respiratory syndrome coronavirus 2 in pleural fluid obtained by means of ultrasound-guided thoracentesis, and its main characteristics are detailed. Pleural effusion is not a common finding in COVID-19 infection, but a prompt recognition of this potential localization may be useful to optimize diagnostic evaluation as well as the management of these patients.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Mei F, Bonifazi M, Menzo S, et al. First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid. Chest. 2020. PMID: 32534909. doi:10.1016/j.chest.2020.05.583

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。